A double-blind trial of colchicine in Behçet's syndrome.

@article{Yurdakul2001ADT,
  title={A double-blind trial of colchicine in Behçet's syndrome.},
  author={S. Yurdakul and C. Mat and Y. T{\"u}z{\"u}n and Y. Ozyazgan and V. Hamuryudan and O. Uysal and M. Şenocak and H. Yazici},
  journal={Arthritis and rheumatism},
  year={2001},
  volume={44 11},
  pages={
          2686-92
        }
}
  • S. Yurdakul, C. Mat, +5 authors H. Yazici
  • Published 2001
  • Medicine
  • Arthritis and rheumatism
  • OBJECTIVE Colchicine is a widely used treatment for Behçet's syndrome, even though in a previous 6-month controlled study, it was shown to be effective only in controlling erythema nodosum and arthralgias. We reassessed the effect of colchicine in Behçet's syndrome in a study conducted among a larger group of patients for 2 years. METHODS We randomized 116 patients with Behçet's syndrome (60 male/56 female), who had active mucocutaneous disease without eye or major organ involvement, to… CONTINUE READING
    286 Citations
    A double-blind trial of depot corticosteroids in Behçet's syndrome.
    • 82
    • PDF
    Colchicine versus placebo in Behçet’s disease: randomized, double-blind, controlled crossover trial
    • 86
    • Highly Influenced
    Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.
    • 119
    Colchicine in Behçet Syndrome: A Longterm Survey of Patients in a Controlled Trial
    • 11
    Apremilast for the treatment of Behcet’s syndrome
    • 6
    A new Mucocutaneous Activity Index for Behçet's disease.
    • 11
    Value of colchicine as treatment for recurrent oral ulcers: a systematic review.
    • M. Cabras, M. Carrozzo, +4 authors P. Arduino
    • Medicine
    • Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
    • 2020
    • 2

    References

    SHOWING 1-10 OF 13 REFERENCES
    A controlled trial of azathioprine in Behçet's syndrome.
    • 255
    Behcet Disease and the Emergence of Thalidomide
    • 31
    Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome.
    • 346
    • PDF
    Colchicine in the treatment of the cutaneous manifestations of Behçet's disease
    • 83
    Neutrophil chemotaxis in Behçet’s syndrome
    • 15
    • PDF
    The ten-year mortality in Behçet's syndrome.
    • 102
    • PDF
    A double blind study of colchicine in Behçet's disease.
    • 156
    COLCHICINE IN BEHÇET'S DISEASE
    • 66
    Colchicine in Behçet’s disease [letter
    • 1977